DSGN

Design Therapeutics, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1807120Held by 3 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

3 managers · Q2 2026 13F

13F bookWeight

Vivo Capital

Vivo CapitalPosition history →

2.1%

—

$23.3M

$1.10B13F book · 2026-06-30

Baker Bros. Advisors

Baker Bros. AdvisorsPosition history →

0.19%

+3.6%

$38.8M

$19.96B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

<0.01%

+26.3%

$0.9M

$21.33B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.